INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Capricor Therapeutics, Inc. – CAPR
I'm PortAI, I can summarize articles.
Pomerantz Law Firm is investigating claims on behalf of investors of Capricor Therapeutics, Inc. (NASDAQ: CAPR) regarding potential securities fraud or unlawful business practices by the company and its officers. Following a mid-cycle review with the FDA concerning Capricor's Biologics License Application for deramiocel, the stock price fell significantly. The investigation is ongoing, and investors are encouraged to contact the firm for more information.
Source: MorningStar The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments